StapleBio, Inc.
PrivateLast Round
VC Round
Apr 1, 2024
Company Overview
StapleBio, Inc. operates in Healthcare & Life Sciences and is based in Kumamoto. Its latest recorded funding round was a VC Round in April 2024.
StapleBio, Inc. is a biotechnology company developing a nucleic acid-based therapeutic platform intended to modulate target protein expression levels for treating various diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StapleBio, Inc. Comparables
Compare StapleBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| xFOREST Therapeutics Co., Ltd. | 81% | |
| HAYA Therapeutics | 77% | |
| Luxna Biotech Co., Ltd. | 75% |
For institutional investors. Book with your work email.
StapleBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 1, 2024 | ||||
| Convertible Debt | Dec 16, 2022 | ||||
| Seed | Jan 24, 2022 |
For institutional investors. Book with your work email.
StapleBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 公益財団法人沖縄科学技術振興センター | Convertible Debt |
| Diamond Medino Capital | VC Round |
| Higin Capital | Convertible Debt, VC Round |
| Taiho Innovations, LLC | Seed |
| Mitsubishi UFJ Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2024
$3M round led by Diamond Medino Capital
- Dec 16, 2022
Raised funding from Higin Capital and KSP, Inc.
For institutional investors. Book with your work email.
StapleBio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about StapleBio, Inc.'s valuation, stock price, and market status.
Is StapleBio, Inc. a public or private company?
StapleBio, Inc. is a private company.
What is the current stock price of StapleBio, Inc.?
StapleBio, Inc. is a private company, so its shares have no public market price. Caplight tracks StapleBio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is StapleBio, Inc. worth (valuation)?
Valuation information for StapleBio, Inc. is not publicly available.
Can I buy StapleBio, Inc. stock?
StapleBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was StapleBio, Inc.'s last funding round?
StapleBio, Inc.'s most recent funding round was VC Round on April 1, 2024.
Who are the main investors in StapleBio, Inc.?
Key investors in StapleBio, Inc. include Diamond Medino Capital, Taiho Innovations, LLC.
Will StapleBio, Inc. IPO soon?
No public IPO plans have been announced for StapleBio, Inc..
How can I track StapleBio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in StapleBio, Inc.'s shares on secondary markets.